Dr.Jucre Rebirth

Manufacturer
NATURECELL CO., LTD. | Cosmax, Inc.
Effective date
2025-01-02
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:50:25

Label at a glance#

ProductDr.Jucre Rebirth
Active ingredientNIACINAMIDE
Label structure10 sections

Indications and uses

■ Helps brighten skin tone

Dosage and administration

■ Apply an appropriate amount evenly on the skin.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Niacinamide 2.0%

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Water, Glycerin, Butylene Glycol, Dimethicone, Cyclopentasiloxane, Cetyl Ethylhexanoate, Cyclohexasiloxane, Butyrospermum Parkii (Shea) Butter, Human Adipose Derived Stem Cell Conditioned Media, Pentylene Glycol, Hydrogenated Vegetable Oil, Polyglyceryl-3 Methylglucose Distearate, Betaine, Glyceryl Stearate, Stearyl Alcohol, Cetyl Alcohol, Chondrus Crispus Extract, Caprylyl Glycol, Sorbitan Stearate, Phenoxyethanol, PEG-100 Stearate, Saccharum Officinarum (Sugarcane) Extract, Citrus Aurantium Bergamia (Bergamot) Fruit Oil, Beeswax, Carbomer, Triethanolamine, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Isohexadecane, Citrus Grandis (Grapefruit) Peel Oil, Sodium Phytate, Xanthan Gum, 1,2-Hexanediol, Polysorbate 80, Sorbitan Oleate, Cynanchum Atratum Extract, Dimethicone/Vinyl Dimethicone Crosspolymer, Myristyl Alcohol, Lauryl Alcohol, Althaea Rosea Flower Extract, Ethylhexylglycerin, Plankton Extract, Hydroxypropyl Cyclodextrin, Thioctic Acid, Tremella Fuciformis (Mushroom) Extract, Potassium Hydroxide

PURPOSE

OTC - PURPOSE SECTION

Skin Brightening

WARNINGS

WARNINGS SECTION

For external use only.
Avoid contact with eyes.
Discontinue use if signs of irritation or rashes appear.
Replace the cap after use.
Refrain from using it on wounded areas.
Keep out of reach of children.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children.

Uses

INDICATIONS & USAGE SECTION

■ Helps brighten skin tone

Directions

DOSAGE & ADMINISTRATION SECTION

■ Apply an appropriate amount evenly on the skin.

Other Information

OTHER SAFETY INFORMATION

■ Do not store this product in an inappropriate place such as high or low temperatures or under direct sun light.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Carton ImageCarton Image

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83071-140-01Dr.Jucre Rebirth120 mL in 1 BOTTLEEMULSION1201
83071-140-02Dr.Jucre Rebirth1 in 1 CARTONEMULSION11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83071-140DR.JUCRE REBIRTH (NIACINAMIDE) EMULSION [NATURECELL CO., LTD.]1Current NDC, 2 package rows20250103_2ab4562d-e8b4-c9a4-e063-6394a90ada47.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83071-14083071-140-01, 83071-140-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Dr.Jucre RebirthNIACINAMIDENATURECELL CO., LTD.2ab4562d-e8b4-c9a4-e063-6394a90ada472025-01-02WarningsExact identifier
ndc (package): 83071-140-01
ndc (package): 83071-140-02
ndc (product): 83071-140
ndc11 (package): 83071014002
ndc11 (package): 83071014001
spl id: 2ab4562d-e8b5-c9a4-e063-6394a90ada47
spl set id: 2ab4562d-e8b4-c9a4-e063-6394a90ada47

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.